✦ LIBER ✦

Successful aggressive withdrawal of prednisone for de novo heart transplant patients in the era of modern immunosuppression

✍ Scribed by M.S. Levy; C. Imai; A.M. Kaan; L. Straatman; A. Ignaszewski

Book ID: 116518635
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 73 KB
Volume: 24
Category: Article
ISSN: 1557-3117
DOI: 10.1016/j.healun.2004.12.043

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

165 Analysis of over 1000 Patients Liste

165 Analysis of over 1000 Patients Listed for Combined Heart-Kidney Transplant in the Modern Era

✍ J.M. Schaffer; S.K. Singh; B.A. Reitz; P.E. Oyer; R.C. Robbins; H.R. Mallidi 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 255 KB

465: More Adverse Events Leading to Drug

465: More Adverse Events Leading to Drug Dose Adjustment/Interruption in the Presence of MMF- vs Everolimus-Based Immunosuppression in De Novo Heart Transplant Patients

✍ E. Vermes; L. Almenar; M. Viganò; M. MacCherini; A. Poncelet; M.-F. Mattei; T. D 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 79 KB

270: BMI Is an Independent Risk Factor f

270: BMI Is an Independent Risk Factor for Surgical Wound Complication in de-novo Heart Transplant Recipients (HTxR) Regardless of the Immunosuppressive Therapy

✍ M.J. Barten; J.M. Arizon; G. Dong; H. Eisen; J. Kobashigawa; H. Lehmkuhl; H. Ros 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Frequency and predictors of de novo hepa

Frequency and predictors of de novo hepatocellular carcinoma in patients awaiting orthotopic liver transplantation during the model for end-stage liver disease era

✍ Carla W. Brady; Alastair D. Smith; Karen M. Stechuchak; Cynthia J. Coffman; Jane 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 1 views

In the current system of allocation, patients awaiting orthotopic liver transplantation (OLT) remain at risk of developing de novo hepatocellular carcinoma (HCC) and removal from the waiting list. Using the United Network for Organ Sharing database, we calculated the rate and identified predictors o

Topical immunomodulation under systemic

Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patients

✍ C. Ulrich; J. Bichel; S. Euvrard; B. Guidi; C.M. Proby; P.C.M. Van De Kerkhof; P 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

682: 1-Year Results of the First 120 Pat

682: 1-Year Results of the First 120 Patients Enrolled in a 3-Year Randomised, Open Label, Multi-Centre Investigator Driven Study Comparing De Novo Enteric Coated Mycophenolate Sodium with Delayed Onset Everolimus, Both Arms in Combination with Cyclosporin (Using C2 Monitoring) and Corticosteroids for the Prevention of Bronchiolitis Obliterans Syndrome in Heart-Lung, Bilateral Lung and Single Lung Transplant Recipients

✍ A.R. Glanville; C. Aboyoun; W. Klepetko; H. Reichenspurner; H. Treede; E. Versch 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 129 KB